Global Anti-tetanus Immunoglobulin Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-tetanus Immunoglobulin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-tetanus Immunoglobulin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-tetanus Immunoglobulin by Country/Region, 2017, 2022 & 2028

2.2 Anti-tetanus Immunoglobulin Segment by Type

2.2.1 Injection

2.2.2 Freeze-dried Injection

2.3 Anti-tetanus Immunoglobulin Sales by Type

2.3.1 Global Anti-tetanus Immunoglobulin Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-tetanus Immunoglobulin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-tetanus Immunoglobulin Sale Price by Type (2017-2022)

2.4 Anti-tetanus Immunoglobulin Segment by Application

2.4.1 Adults

2.4.2 Children

2.5 Anti-tetanus Immunoglobulin Sales by Application

2.5.1 Global Anti-tetanus Immunoglobulin Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-tetanus Immunoglobulin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-tetanus Immunoglobulin Sale Price by Application (2017-2022)

3 Global Anti-tetanus Immunoglobulin by Company

3.1 Global Anti-tetanus Immunoglobulin Breakdown Data by Company

3.1.1 Global Anti-tetanus Immunoglobulin Annual Sales by Company (2020-2022)

3.1.2 Global Anti-tetanus Immunoglobulin Sales Market Share by Company (2020-2022)

3.2 Global Anti-tetanus Immunoglobulin Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-tetanus Immunoglobulin Revenue by Company (2020-2022)

3.2.2 Global Anti-tetanus Immunoglobulin Revenue Market Share by Company (2020-2022)

3.3 Global Anti-tetanus Immunoglobulin Sale Price by Company

3.4 Key Manufacturers Anti-tetanus Immunoglobulin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-tetanus Immunoglobulin Product Location Distribution

3.4.2 Players Anti-tetanus Immunoglobulin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-tetanus Immunoglobulin by Geographic Region

4.1 World Historic Anti-tetanus Immunoglobulin Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-tetanus Immunoglobulin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-tetanus Immunoglobulin Annual Revenue by Geographic Region

4.2 World Historic Anti-tetanus Immunoglobulin Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-tetanus Immunoglobulin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-tetanus Immunoglobulin Annual Revenue by Country/Region

4.3 Americas Anti-tetanus Immunoglobulin Sales Growth

4.4 APAC Anti-tetanus Immunoglobulin Sales Growth

4.5 Europe Anti-tetanus Immunoglobulin Sales Growth

4.6 Middle East & Africa Anti-tetanus Immunoglobulin Sales Growth

5 Americas

5.1 Americas Anti-tetanus Immunoglobulin Sales by Country

5.1.1 Americas Anti-tetanus Immunoglobulin Sales by Country (2017-2022)

5.1.2 Americas Anti-tetanus Immunoglobulin Revenue by Country (2017-2022)

5.2 Americas Anti-tetanus Immunoglobulin Sales by Type

5.3 Americas Anti-tetanus Immunoglobulin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-tetanus Immunoglobulin Sales by Region

6.1.1 APAC Anti-tetanus Immunoglobulin Sales by Region (2017-2022)

6.1.2 APAC Anti-tetanus Immunoglobulin Revenue by Region (2017-2022)

6.2 APAC Anti-tetanus Immunoglobulin Sales by Type

6.3 APAC Anti-tetanus Immunoglobulin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-tetanus Immunoglobulin by Country

7.1.1 Europe Anti-tetanus Immunoglobulin Sales by Country (2017-2022)

7.1.2 Europe Anti-tetanus Immunoglobulin Revenue by Country (2017-2022)

7.2 Europe Anti-tetanus Immunoglobulin Sales by Type

7.3 Europe Anti-tetanus Immunoglobulin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-tetanus Immunoglobulin by Country

8.1.1 Middle East & Africa Anti-tetanus Immunoglobulin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-tetanus Immunoglobulin Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-tetanus Immunoglobulin Sales by Type

8.3 Middle East & Africa Anti-tetanus Immunoglobulin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-tetanus Immunoglobulin

10.3 Manufacturing Process Analysis of Anti-tetanus Immunoglobulin

10.4 Industry Chain Structure of Anti-tetanus Immunoglobulin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-tetanus Immunoglobulin Distributors

11.3 Anti-tetanus Immunoglobulin Customer

12 World Forecast Review for Anti-tetanus Immunoglobulin by Geographic Region

12.1 Global Anti-tetanus Immunoglobulin Market Size Forecast by Region

12.1.1 Global Anti-tetanus Immunoglobulin Forecast by Region (2023-2028)

12.1.2 Global Anti-tetanus Immunoglobulin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-tetanus Immunoglobulin Forecast by Type

12.7 Global Anti-tetanus Immunoglobulin Forecast by Application

13 Key Players Analysis

13.1 SK Plasma

13.1.1 SK Plasma Company Information

13.1.2 SK Plasma Anti-tetanus Immunoglobulin Product Offered

13.1.3 SK Plasma Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 SK Plasma Main Business Overview

13.1.5 SK Plasma Latest Developments

13.2 Baxalta

13.2.1 Baxalta Company Information

13.2.2 Baxalta Anti-tetanus Immunoglobulin Product Offered

13.2.3 Baxalta Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Baxalta Main Business Overview

13.2.5 Baxalta Latest Developments

13.3 CSL

13.3.1 CSL Company Information

13.3.2 CSL Anti-tetanus Immunoglobulin Product Offered

13.3.3 CSL Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CSL Main Business Overview

13.3.5 CSL Latest Developments

13.4 Octapharma

13.4.1 Octapharma Company Information

13.4.2 Octapharma Anti-tetanus Immunoglobulin Product Offered

13.4.3 Octapharma Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Octapharma Main Business Overview

13.4.5 Octapharma Latest Developments

13.5 Grifols

13.5.1 Grifols Company Information

13.5.2 Grifols Anti-tetanus Immunoglobulin Product Offered

13.5.3 Grifols Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Grifols Main Business Overview

13.5.5 Grifols Latest Developments

13.6 LFB

13.6.1 LFB Company Information

13.6.2 LFB Anti-tetanus Immunoglobulin Product Offered

13.6.3 LFB Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 LFB Main Business Overview

13.6.5 LFB Latest Developments

13.7 Biotest

13.7.1 Biotest Company Information

13.7.2 Biotest Anti-tetanus Immunoglobulin Product Offered

13.7.3 Biotest Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Biotest Main Business Overview

13.7.5 Biotest Latest Developments

13.8 Kedrion

13.8.1 Kedrion Company Information

13.8.2 Kedrion Anti-tetanus Immunoglobulin Product Offered

13.8.3 Kedrion Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Kedrion Main Business Overview

13.8.5 Kedrion Latest Developments

13.9 Hualan Biological Engineering

13.9.1 Hualan Biological Engineering Company Information

13.9.2 Hualan Biological Engineering Anti-tetanus Immunoglobulin Product Offered

13.9.3 Hualan Biological Engineering Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Hualan Biological Engineering Main Business Overview

13.9.5 Hualan Biological Engineering Latest Developments

13.10 Sinopharm

13.10.1 Sinopharm Company Information

13.10.2 Sinopharm Anti-tetanus Immunoglobulin Product Offered

13.10.3 Sinopharm Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Sinopharm Main Business Overview

13.10.5 Sinopharm Latest Developments

13.11 Hualan Bio-Engineering

13.11.1 Hualan Bio-Engineering Company Information

13.11.2 Hualan Bio-Engineering Anti-tetanus Immunoglobulin Product Offered

13.11.3 Hualan Bio-Engineering Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Hualan Bio-Engineering Main Business Overview

13.11.5 Hualan Bio-Engineering Latest Developments

13.12 Nanyue Bio-Pharmaceutical

13.12.1 Nanyue Bio-Pharmaceutical Company Information

13.12.2 Nanyue Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product Offered

13.12.3 Nanyue Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Nanyue Bio-Pharmaceutical Main Business Overview

13.12.5 Nanyue Bio-Pharmaceutical Latest Developments

13.13 Tonglu Bio-Pharmaceutical

13.13.1 Tonglu Bio-Pharmaceutical Company Information

13.13.2 Tonglu Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product Offered

13.13.3 Tonglu Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Tonglu Bio-Pharmaceutical Main Business Overview

13.13.5 Tonglu Bio-Pharmaceutical Latest Developments

13.14 Sichuan Yuanda Shuyang Pharmaceutical

13.14.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information

13.14.2 Sichuan Yuanda Shuyang Pharmaceutical Anti-tetanus Immunoglobulin Product Offered

13.14.3 Sichuan Yuanda Shuyang Pharmaceutical Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Sichuan Yuanda Shuyang Pharmaceutical Main Business Overview

13.14.5 Sichuan Yuanda Shuyang Pharmaceutical Latest Developments

13.15 Wuhan Central Plain Ruide Bio-Products

13.15.1 Wuhan Central Plain Ruide Bio-Products Company Information

13.15.2 Wuhan Central Plain Ruide Bio-Products Anti-tetanus Immunoglobulin Product Offered

13.15.3 Wuhan Central Plain Ruide Bio-Products Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Wuhan Central Plain Ruide Bio-Products Main Business Overview

13.15.5 Wuhan Central Plain Ruide Bio-Products Latest Developments

13.16 Shandong Taibang Bio-Products

13.16.1 Shandong Taibang Bio-Products Company Information

13.16.2 Shandong Taibang Bio-Products Anti-tetanus Immunoglobulin Product Offered

13.16.3 Shandong Taibang Bio-Products Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Shandong Taibang Bio-Products Main Business Overview

13.16.5 Shandong Taibang Bio-Products Latest Developments

13.17 Guangdong Shuanglin Bio-Pharmaceutical

13.17.1 Guangdong Shuanglin Bio-Pharmaceutical Company Information

13.17.2 Guangdong Shuanglin Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product Offered

13.17.3 Guangdong Shuanglin Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Guangdong Shuanglin Bio-Pharmaceutical Main Business Overview

13.17.5 Guangdong Shuanglin Bio-Pharmaceutical Latest Developments

13.18 Chengdu Rongsheng Pharmaceutical

13.18.1 Chengdu Rongsheng Pharmaceutical Company Information

13.18.2 Chengdu Rongsheng Pharmaceutical Anti-tetanus Immunoglobulin Product Offered

13.18.3 Chengdu Rongsheng Pharmaceutical Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Chengdu Rongsheng Pharmaceutical Main Business Overview

13.18.5 Chengdu Rongsheng Pharmaceutical Latest Developments

13.19 Shenzhen Weiguang Bio-Products

13.19.1 Shenzhen Weiguang Bio-Products Company Information

13.19.2 Shenzhen Weiguang Bio-Products Anti-tetanus Immunoglobulin Product Offered

13.19.3 Shenzhen Weiguang Bio-Products Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Shenzhen Weiguang Bio-Products Main Business Overview

13.19.5 Shenzhen Weiguang Bio-Products Latest Developments

13.20 Guizhou Taibang Bio-Products

13.20.1 Guizhou Taibang Bio-Products Company Information

13.20.2 Guizhou Taibang Bio-Products Anti-tetanus Immunoglobulin Product Offered

13.20.3 Guizhou Taibang Bio-Products Anti-tetanus Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Guizhou Taibang Bio-Products Main Business Overview

13.20.5 Guizhou Taibang Bio-Products Latest Developments

14 Research Findings and Conclusion

Table 1. Anti-tetanus Immunoglobulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-tetanus Immunoglobulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Injection

Table 4. Major Players of Freeze-dried Injection

Table 5. Global Anti-tetanus Immunoglobulin Sales by Type (2017-2022) & (K Doses)

Table 6. Global Anti-tetanus Immunoglobulin Sales Market Share by Type (2017-2022)

Table 7. Global Anti-tetanus Immunoglobulin Revenue by Type (2017-2022) & ($ million)

Table 8. Global Anti-tetanus Immunoglobulin Revenue Market Share by Type (2017-2022)

Table 9. Global Anti-tetanus Immunoglobulin Sale Price by Type (2017-2022) & (US$/Dose)

Table 10. Global Anti-tetanus Immunoglobulin Sales by Application (2017-2022) & (K Doses)

Table 11. Global Anti-tetanus Immunoglobulin Sales Market Share by Application (2017-2022)

Table 12. Global Anti-tetanus Immunoglobulin Revenue by Application (2017-2022)

Table 13. Global Anti-tetanus Immunoglobulin Revenue Market Share by Application (2017-2022)

Table 14. Global Anti-tetanus Immunoglobulin Sale Price by Application (2017-2022) & (US$/Dose)

Table 15. Global Anti-tetanus Immunoglobulin Sales by Company (2020-2022) & (K Doses)

Table 16. Global Anti-tetanus Immunoglobulin Sales Market Share by Company (2020-2022)

Table 17. Global Anti-tetanus Immunoglobulin Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Anti-tetanus Immunoglobulin Revenue Market Share by Company (2020-2022)

Table 19. Global Anti-tetanus Immunoglobulin Sale Price by Company (2020-2022) & (US$/Dose)

Table 20. Key Manufacturers Anti-tetanus Immunoglobulin Producing Area Distribution and Sales Area

Table 21. Players Anti-tetanus Immunoglobulin Products Offered

Table 22. Anti-tetanus Immunoglobulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Anti-tetanus Immunoglobulin Sales by Geographic Region (2017-2022) & (K Doses)

Table 26. Global Anti-tetanus Immunoglobulin Sales Market Share Geographic Region (2017-2022)

Table 27. Global Anti-tetanus Immunoglobulin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Anti-tetanus Immunoglobulin Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Anti-tetanus Immunoglobulin Sales by Country/Region (2017-2022) & (K Doses)

Table 30. Global Anti-tetanus Immunoglobulin Sales Market Share by Country/Region (2017-2022)

Table 31. Global Anti-tetanus Immunoglobulin Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Anti-tetanus Immunoglobulin Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Anti-tetanus Immunoglobulin Sales by Country (2017-2022) & (K Doses)

Table 34. Americas Anti-tetanus Immunoglobulin Sales Market Share by Country (2017-2022)

Table 35. Americas Anti-tetanus Immunoglobulin Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Anti-tetanus Immunoglobulin Revenue Market Share by Country (2017-2022)

Table 37. Americas Anti-tetanus Immunoglobulin Sales by Type (2017-2022) & (K Doses)

Table 38. Americas Anti-tetanus Immunoglobulin Sales Market Share by Type (2017-2022)

Table 39. Americas Anti-tetanus Immunoglobulin Sales by Application (2017-2022) & (K Doses)

Table 40. Americas Anti-tetanus Immunoglobulin Sales Market Share by Application (2017-2022)

Table 41. APAC Anti-tetanus Immunoglobulin Sales by Region (2017-2022) & (K Doses)

Table 42. APAC Anti-tetanus Immunoglobulin Sales Market Share by Region (2017-2022)

Table 43. APAC Anti-tetanus Immunoglobulin Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Anti-tetanus Immunoglobulin Revenue Market Share by Region (2017-2022)

Table 45. APAC Anti-tetanus Immunoglobulin Sales by Type (2017-2022) & (K Doses)

Table 46. APAC Anti-tetanus Immunoglobulin Sales Market Share by Type (2017-2022)

Table 47. APAC Anti-tetanus Immunoglobulin Sales by Application (2017-2022) & (K Doses)

Table 48. APAC Anti-tetanus Immunoglobulin Sales Market Share by Application (2017-2022)

Table 49. Europe Anti-tetanus Immunoglobulin Sales by Country (2017-2022) & (K Doses)

Table 50. Europe Anti-tetanus Immunoglobulin Sales Market Share by Country (2017-2022)

Table 51. Europe Anti-tetanus Immunoglobulin Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Anti-tetanus Immunoglobulin Revenue Market Share by Country (2017-2022)

Table 53. Europe Anti-tetanus Immunoglobulin Sales by Type (2017-2022) & (K Doses)

Table 54. Europe Anti-tetanus Immunoglobulin Sales Market Share by Type (2017-2022)

Table 55. Europe Anti-tetanus Immunoglobulin Sales by Application (2017-2022) & (K Doses)

Table 56. Europe Anti-tetanus Immunoglobulin Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Anti-tetanus Immunoglobulin Sales by Country (2017-2022) & (K Doses)

Table 58. Middle East & Africa Anti-tetanus Immunoglobulin Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Anti-tetanus Immunoglobulin Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Anti-tetanus Immunoglobulin Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Anti-tetanus Immunoglobulin Sales by Type (2017-2022) & (K Doses)

Table 62. Middle East & Africa Anti-tetanus Immunoglobulin Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Anti-tetanus Immunoglobulin Sales by Application (2017-2022) & (K Doses)

Table 64. Middle East & Africa Anti-tetanus Immunoglobulin Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Anti-tetanus Immunoglobulin

Table 66. Key Market Challenges & Risks of Anti-tetanus Immunoglobulin

Table 67. Key Industry Trends of Anti-tetanus Immunoglobulin

Table 68. Anti-tetanus Immunoglobulin Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Anti-tetanus Immunoglobulin Distributors List

Table 71. Anti-tetanus Immunoglobulin Customer List

Table 72. Global Anti-tetanus Immunoglobulin Sales Forecast by Region (2023-2028) & (K Doses)

Table 73. Global Anti-tetanus Immunoglobulin Sales Market Forecast by Region

Table 74. Global Anti-tetanus Immunoglobulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Anti-tetanus Immunoglobulin Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Anti-tetanus Immunoglobulin Sales Forecast by Country (2023-2028) & (K Doses)

Table 77. Americas Anti-tetanus Immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Anti-tetanus Immunoglobulin Sales Forecast by Region (2023-2028) & (K Doses)

Table 79. APAC Anti-tetanus Immunoglobulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Anti-tetanus Immunoglobulin Sales Forecast by Country (2023-2028) & (K Doses)

Table 81. Europe Anti-tetanus Immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Anti-tetanus Immunoglobulin Sales Forecast by Country (2023-2028) & (K Doses)

Table 83. Middle East & Africa Anti-tetanus Immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Anti-tetanus Immunoglobulin Sales Forecast by Type (2023-2028) & (K Doses)

Table 85. Global Anti-tetanus Immunoglobulin Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Anti-tetanus Immunoglobulin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Anti-tetanus Immunoglobulin Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Anti-tetanus Immunoglobulin Sales Forecast by Application (2023-2028) & (K Doses)

Table 89. Global Anti-tetanus Immunoglobulin Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Anti-tetanus Immunoglobulin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Anti-tetanus Immunoglobulin Revenue Market Share Forecast by Application (2023-2028)

Table 92. SK Plasma Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 93. SK Plasma Anti-tetanus Immunoglobulin Product Offered

Table 94. SK Plasma Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 95. SK Plasma Main Business

Table 96. SK Plasma Latest Developments

Table 97. Baxalta Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 98. Baxalta Anti-tetanus Immunoglobulin Product Offered

Table 99. Baxalta Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 100. Baxalta Main Business

Table 101. Baxalta Latest Developments

Table 102. CSL Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 103. CSL Anti-tetanus Immunoglobulin Product Offered

Table 104. CSL Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 105. CSL Main Business

Table 106. CSL Latest Developments

Table 107. Octapharma Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 108. Octapharma Anti-tetanus Immunoglobulin Product Offered

Table 109. Octapharma Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 110. Octapharma Main Business

Table 111. Octapharma Latest Developments

Table 112. Grifols Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 113. Grifols Anti-tetanus Immunoglobulin Product Offered

Table 114. Grifols Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 115. Grifols Main Business

Table 116. Grifols Latest Developments

Table 117. LFB Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 118. LFB Anti-tetanus Immunoglobulin Product Offered

Table 119. LFB Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 120. LFB Main Business

Table 121. LFB Latest Developments

Table 122. Biotest Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 123. Biotest Anti-tetanus Immunoglobulin Product Offered

Table 124. Biotest Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 125. Biotest Main Business

Table 126. Biotest Latest Developments

Table 127. Kedrion Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 128. Kedrion Anti-tetanus Immunoglobulin Product Offered

Table 129. Kedrion Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 130. Kedrion Main Business

Table 131. Kedrion Latest Developments

Table 132. Hualan Biological Engineering Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 133. Hualan Biological Engineering Anti-tetanus Immunoglobulin Product Offered

Table 134. Hualan Biological Engineering Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 135. Hualan Biological Engineering Main Business

Table 136. Hualan Biological Engineering Latest Developments

Table 137. Sinopharm Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 138. Sinopharm Anti-tetanus Immunoglobulin Product Offered

Table 139. Sinopharm Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 140. Sinopharm Main Business

Table 141. Sinopharm Latest Developments

Table 142. Hualan Bio-Engineering Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 143. Hualan Bio-Engineering Anti-tetanus Immunoglobulin Product Offered

Table 144. Hualan Bio-Engineering Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 145. Hualan Bio-Engineering Main Business

Table 146. Hualan Bio-Engineering Latest Developments

Table 147. Nanyue Bio-Pharmaceutical Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 148. Nanyue Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product Offered

Table 149. Nanyue Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 150. Nanyue Bio-Pharmaceutical Main Business

Table 151. Nanyue Bio-Pharmaceutical Latest Developments

Table 152. Tonglu Bio-Pharmaceutical Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 153. Tonglu Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product Offered

Table 154. Tonglu Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 155. Tonglu Bio-Pharmaceutical Main Business

Table 156. Tonglu Bio-Pharmaceutical Latest Developments

Table 157. Sichuan Yuanda Shuyang Pharmaceutical Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 158. Sichuan Yuanda Shuyang Pharmaceutical Anti-tetanus Immunoglobulin Product Offered

Table 159. Sichuan Yuanda Shuyang Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 160. Sichuan Yuanda Shuyang Pharmaceutical Main Business

Table 161. Sichuan Yuanda Shuyang Pharmaceutical Latest Developments

Table 162. Wuhan Central Plain Ruide Bio-Products Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 163. Wuhan Central Plain Ruide Bio-Products Anti-tetanus Immunoglobulin Product Offered

Table 164. Wuhan Central Plain Ruide Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 165. Wuhan Central Plain Ruide Bio-Products Main Business

Table 166. Wuhan Central Plain Ruide Bio-Products Latest Developments

Table 167. Shandong Taibang Bio-Products Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 168. Shandong Taibang Bio-Products Anti-tetanus Immunoglobulin Product Offered

Table 169. Shandong Taibang Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 170. Shandong Taibang Bio-Products Main Business

Table 171. Shandong Taibang Bio-Products Latest Developments

Table 172. Guangdong Shuanglin Bio-Pharmaceutical Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 173. Guangdong Shuanglin Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product Offered

Table 174. Guangdong Shuanglin Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 175. Guangdong Shuanglin Bio-Pharmaceutical Main Business

Table 176. Guangdong Shuanglin Bio-Pharmaceutical Latest Developments

Table 177. Chengdu Rongsheng Pharmaceutical Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 178. Chengdu Rongsheng Pharmaceutical Anti-tetanus Immunoglobulin Product Offered

Table 179. Chengdu Rongsheng Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 180. Chengdu Rongsheng Pharmaceutical Main Business

Table 181. Chengdu Rongsheng Pharmaceutical Latest Developments

Table 182. Shenzhen Weiguang Bio-Products Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 183. Shenzhen Weiguang Bio-Products Anti-tetanus Immunoglobulin Product Offered

Table 184. Shenzhen Weiguang Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 185. Shenzhen Weiguang Bio-Products Main Business

Table 186. Shenzhen Weiguang Bio-Products Latest Developments

Table 187. Guizhou Taibang Bio-Products Basic Information, Anti-tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 188. Guizhou Taibang Bio-Products Anti-tetanus Immunoglobulin Product Offered

Table 189. Guizhou Taibang Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 190. Guizhou Taibang Bio-Products Main Business

Table 191. Guizhou Taibang Bio-Products Latest Developments

List of Figures

Figure 1. Picture of Anti-tetanus Immunoglobulin

Figure 2. Anti-tetanus Immunoglobulin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-tetanus Immunoglobulin Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Anti-tetanus Immunoglobulin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-tetanus Immunoglobulin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Injection

Figure 10. Product Picture of Freeze-dried Injection

Figure 11. Global Anti-tetanus Immunoglobulin Sales Market Share by Type in 2021

Figure 12. Global Anti-tetanus Immunoglobulin Revenue Market Share by Type (2017-2022)

Figure 13. Anti-tetanus Immunoglobulin Consumed in Adults

Figure 14. Global Anti-tetanus Immunoglobulin Market: Adults (2017-2022) & (K Doses)

Figure 15. Anti-tetanus Immunoglobulin Consumed in Children

Figure 16. Global Anti-tetanus Immunoglobulin Market: Children (2017-2022) & (K Doses)

Figure 17. Global Anti-tetanus Immunoglobulin Sales Market Share by Application (2017-2022)

Figure 18. Global Anti-tetanus Immunoglobulin Revenue Market Share by Application in 2021

Figure 19. Anti-tetanus Immunoglobulin Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Anti-tetanus Immunoglobulin Revenue Market Share by Company in 2021

Figure 21. Global Anti-tetanus Immunoglobulin Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Anti-tetanus Immunoglobulin Revenue Market Share by Geographic Region in 2021

Figure 23. Global Anti-tetanus Immunoglobulin Sales Market Share by Region (2017-2022)

Figure 24. Global Anti-tetanus Immunoglobulin Revenue Market Share by Country/Region in 2021

Figure 25. Americas Anti-tetanus Immunoglobulin Sales 2017-2022 (K Doses)

Figure 26. Americas Anti-tetanus Immunoglobulin Revenue 2017-2022 ($ Millions)

Figure 27. APAC Anti-tetanus Immunoglobulin Sales 2017-2022 (K Doses)

Figure 28. APAC Anti-tetanus Immunoglobulin Revenue 2017-2022 ($ Millions)

Figure 29. Europe Anti-tetanus Immunoglobulin Sales 2017-2022 (K Doses)

Figure 30. Europe Anti-tetanus Immunoglobulin Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Anti-tetanus Immunoglobulin Sales 2017-2022 (K Doses)

Figure 32. Middle East & Africa Anti-tetanus Immunoglobulin Revenue 2017-2022 ($ Millions)

Figure 33. Americas Anti-tetanus Immunoglobulin Sales Market Share by Country in 2021

Figure 34. Americas Anti-tetanus Immunoglobulin Revenue Market Share by Country in 2021

Figure 35. United States Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Anti-tetanus Immunoglobulin Sales Market Share by Region in 2021

Figure 40. APAC Anti-tetanus Immunoglobulin Revenue Market Share by Regions in 2021

Figure 41. China Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Anti-tetanus Immunoglobulin Sales Market Share by Country in 2021

Figure 48. Europe Anti-tetanus Immunoglobulin Revenue Market Share by Country in 2021

Figure 49. Germany Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Anti-tetanus Immunoglobulin Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Anti-tetanus Immunoglobulin Revenue Market Share by Country in 2021

Figure 56. Egypt Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Anti-tetanus Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Anti-tetanus Immunoglobulin in 2021

Figure 62. Manufacturing Process Analysis of Anti-tetanus Immunoglobulin

Figure 63. Industry Chain Structure of Anti-tetanus Immunoglobulin

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles